highly significantp < 0.001
The percent reduction in the test drug treated group was highly significant (p < 0.001) as compared to the placebo group ( Table 7 ). 3.5 Post-prandial blood glucose (PPBG) Blood glucose post-prandial showed significant reduction (p < 0.001) from 276.8 ± 59.7 mg/dL to 191.9 ± 49.3 mg/dL in test drug group as compared to placebo group where post-prandial blood glucose reduced from 294.9 ± 56.3 mg/dL to 262.6 ± 52.9 mg/dL ( Table 8 ). 3.5.1 Glycosylated haemoglobin Glycosylated haemoglobin significantly (p = 0.001) decreased from 9.56 ± 1.15 to 7.58 ± 0.99 in the test drug group.